Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 141.80

+0.6%

Dec 31 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1144)	6/18/2003 11:47:01 AM
From: keokalani'nui	Read Replies (1) of 1834

After pfe's analyst meeting, gs's pharma analyst apparently brought indiplone sales into model for first time: est. $700m peak and a late '04 launch. (nbix must not be followed by GS or that change would have been made 6 months ago.) Late '04 sounds sooner than I've heard before.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next